
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Poll: Most are satisfied with their health insurance, but a quarter report denials or delays14.12.2025 - 2
Revealing the Incomparable Realms: An Excursion through Power and Inheritance30.06.2023 - 3
Poland open to German troops to help secure Ukraine ceasefire07.01.2026 - 4
Savvy Cleaning: The 6 Robot Vacuums of 202406.06.2024 - 5
Israel’s mixed messaging on Christmas draws controversy25.12.2025
Startled Venezuelans express relief but also fear after Maduro arrest
Weight-loss pill approval set to accelerate food industry product overhauls
Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
Figure out How to Augment the Advantages of a Web-based Degree
Current Chateaus: Advancement and Style
Vote in favor of your Number one Kind of Gems
New Year's Eve Live: Nashville's Big Bash: How to watch the star-studded country music special live
The Best 10 Innovation Advancements of the Year
6 Methods for further developing Rest Quality













